31 January 2013
The first new tuberculosis (TB) treatment in 50 years has recently been approved in the US and efforts are now being made to make it available in South African hospitals.
The new drug, bedaquiline, treats multidrug-resistant TB (MDR-TB) and costs less than the TB treatment currently available.
Bedaquiline is believed to shorten the treatment time of TB patients...read the full article
blog comments powered by Disqus